Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA awards orphan drug status to Sparsentan for focal segmental glomerulosclerosis

Jan. 13, 2015

Keryx Biopharmaceuticals launches Auryxia in the U.S.

Dec. 24, 2014

Xiapex receives positive opinion by CHMP for Peyronie's disease

Dec. 23, 2014

Taiho Pharmaceutical patents novel compounds for urinary incontinence

Dec. 16, 2014

Phase II data for sotatercept as treatment of anemia in hemodialysis subjects

Dec. 12, 2014

Researchers present phase III clinical data for ZS-9 as treatment of hyperkalemia

Dec. 2, 2014

Kissei Pharmaceutical discloses new TRPM8 antagonists

Nov. 24, 2014

Studies compare time to ESRD in aHUS patients treated with supportive care or eculizumab

Nov. 24, 2014

Kissei Pharmaceutical submits NDA in Japan for PA-21

Nov. 20, 2014

Daiichi Sankyo patents new phosphate transporter inhibitors

Nov. 12, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026